Lv1
45 积分 2020-06-01 加入
CAR T therapy beyond cancer: the evolution of a living drug
12天前
已完结
Targeting metabolic dysregulation for fibrosis therapy
20天前
已完结
Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis
24天前
已完结
Protective effects of heterophyllin B against bleomycin-induced pulmonary fibrosis in mice via AMPK activation
28天前
已完结
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
3个月前
已完结
Checkpoint inhibitors and anti-angiogenic agents: a winning combination
8个月前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
9个月前
已完结
Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine
10个月前
已完结
Regulation of Tumor Dendritic Cells by Programmed Cell Death 1 Pathways
11个月前
已完结
Bortezomib Induces Immunogenic Cell Death in Multiple Myeloma
2年前
已完结
皖公网安备34019202002308
